Point-of-Care Glucose Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others), By Region, and Competition, 2019-2029F
Global Point-of-Care Glucose Testing Market was valued at USD 3.30 billion in 2023 and is anticipated t%li%project steady growth in the forecast period with a CAGR of 4.20% through 2029. Point-of-Care Glucose Testing are the measurement of glucose levels in a patient's blood at the point of care, which can be a hospital, clinic, doctor's office, or even at home. This type of Monitor allows healthcare professionals and patients t%li%quickly assess blood glucose levels without the need for sending samples t%li%a central laboratory, which can lead t%li%faster diagnosis and treatment decisions, particularly in cases of diabetes management. Point-of-Care Glucose Testing refers t%li%the commercial landscape involving the products, devices, and services related t%li%Point-of-Care Glucose Testing. This market encompasses a wide range of technologies, such as blood glucose meters, continuous glucose monitoring (CGM) systems, test strips, and other associated products. The market includes both professional use (healthcare providers conducting tests on patients) and self-monitoring by patients themselves.
Key Market Drivers
Increasing Prevalence of Diabetes Drives The Market Growth
The increasing prevalence of diabetes is a significant driver behind the growth of the global Point of Care Glucose Monitor (POCT) market. Diabetes is a chronic medical condition characterized by elevated blood glucose levels, and its rising prevalence has created a strong demand for effective and convenient glucose monitoring solutions. People with diabetes require regular monitoring of their blood glucose levels t%li%manage the disease effectively. Monitoring helps them make informed decisions about diet, exercise, medication, and insulin dosages. Point-of-Care Glucose Testing provides a quick and convenient way t%li%monitor blood glucose levels without the need for laboratory visits, making it easier for individuals t%li%adhere t%li%their monitoring regimen. Early detection of diabetes and prediabetes is crucial for preventing complications and managing the disease.
As the prevalence of diabetes increases, there is a greater emphasis on early diagnosis and intervention t%li%prevent or delay the onset of complications such as cardiovascular diseases, kidney problems, and nerve damage. Point-of-Care Glucose Testing enables timely detection and intervention, leading t%li%better outcomes for patients. With the increasing prevalence of diabetes, there is a growing focus on patient empowerment and self-management. Point-of-Care Glucose Testing empowers individuals with diabetes t%li%take control of their health by enabling them t%li%monitor their blood glucose levels at home or on the go. This empowerment promotes better engagement in self-care and treatment adherence. The economic burden of diabetes is substantial, with costs associated with medical care, hospitalization, medications, and complications. Healthcare systems are seeking cost-effective solutions t%li%manage diabetes. Point-of-Care Glucose Testing can help reduce costs by minimizing the need for frequent laboratory Monitor and hospital admissions, leading t%li%more efficient resource utilization.
Increasing Demand for Immediate Results
The increasing demand for immediate results is a significant driver behind the growth of the global Point of Care Glucose Monitor (POCT) market. In various healthcare settings, the ability t%li%obtain rapid test results has become a crucial factor for effective patient care and decision-making. For patients with diabetes, prompt adjustments t%li%medication, insulin dosages, and dietary choices are essential for maintaining optimal blood glucose levels. Point-of-Care Glucose Testing provides immediate results, enabling healthcare providers t%li%make real-time decisions about treatment modifications during patient visits. This timely response helps prevent hyperglycemia, hypoglycemia, and associated complications. In emergency departments and critical care units, quick access t%li%diagnostic information is crucial for assessing patients' conditions and determining appropriate interventions. Point-of-Care Glucose Testing allows healthcare professionals t%li%rapidly assess glucose levels in patients wh%li%may be in critical conditions, ensuring timely and appropriate care.
In outpatient settings, primary care clinics, and specialty clinics, healthcare providers often need t%li%make rapid clinical decisions based on test results. Point-of-Care Glucose Testing provides immediate data, allowing clinicians t%li%make informed decisions about treatment plans, medication adjustments, and referrals t%li%specialists. Patients value convenience in healthcare. Immediate test results provided by Point-of-Care Glucose Testing reduce waiting times and the need for follow-up appointments solely for test result discussions. This convenience enhances the patient experience and encourages regular monitoring and engagement in their own care. Point-of-Care Glucose Testing streamlines clinical workflows by eliminating the need t%li%send samples t%li%central laboratories and wait for results. This efficiency benefits both patients and healthcare providers, leading t%li%improved resource utilization and patient throughput. Rapid access t%li%glucose test results helps prevent diabetes-related complications. Healthcare providers can identify glucose fluctuations quickly and intervene t%li%avoid dangerous situations such as hypoglycemic episodes, which can lead t%li%unconsciousness or even death.
Aging Population Drive the Market Growth
The aging population is a significant driver behind the growth of the Point of Care Glucose Monitor (POCT) market. As the global population continues t%li%age, there is a higher prevalence of chronic conditions such as diabetes, which necessitates more frequent and convenient monitoring of blood glucose levels. The aging process is often associated with an increased risk of developing chronic diseases, including type 2 diabetes. Older individuals are more susceptible t%li%insulin resistance and other factors that contribute t%li%elevated blood glucose levels. This results in a higher prevalence of diabetes among the elderly population. Older adults frequently have multiple health conditions that require ongoing management. Diabetes management becomes more complex when combined with other conditions such as hypertension, cardiovascular disease, and kidney problems. Point-of-Care Glucose Testing offers a convenient way t%li%monitor glucose levels, making it easier t%li%integrate diabetes management int%li%the overall care plan.
Healthcare systems are placing greater emphasis on preventive care and early intervention t%li%manage chronic conditions and prevent complications. Point-of-Care Glucose Testing aligns with this approach, allowing healthcare providers t%li%monitor blood glucose levels in older adults and intervene promptly t%li%prevent adverse outcomes. Older adults may experience rapid fluctuations in blood glucose levels due t%li%factors such as medications, changes in diet, and reduced physical activity. Point-of-Care Glucose Testing provides immediate results, enabling healthcare professionals t%li%make timely adjustments t%li%medications and treatment plans t%li%maintain stable glucose levels. Many elderly individuals are on multiple medications. Some medications can impact blood glucose levels, and monitoring glucose levels becomes essential t%li%ensure that medication regimens are well-adjusted and safe for older patients.
Key Market Challenges
Accuracy and Precision
Accuracy and precision are crucial factors in the effectiveness of glucose Monitor, particularly in the Point of Care Glucose Monitor (POCT) market. Inaccurate or imprecise glucose measurements can lead t%li%incorrect treatment decisions, compromised patient safety, and unreliable data for diabetes management. Inaccurate glucose measurements can lead t%li%improper treatment decisions, such as incorrect insulin dosages. This can result in hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), both of which can have serious health consequences, including loss of consciousness or diabetic ketoacidosis. Healthcare providers rely on accurate glucose measurements t%li%make informed treatment decisions. Inaccurate readings can lead t%li%inappropriate adjustments in medication, insulin therapy, or diet, potentially affecting patients' overall health and diabetes management. Inaccurate glucose measurements can lead t%li%suboptimal glycemic control, which is associated with increased risks of diabetes-related complications such as cardiovascular diseases, kidney problems, and neuropathy.
User Training and Proficiency
User training and proficiency are critical challenges in the Global Point of Care Glucose Monitor (POCT) market. The accurate and effective use of glucose Monitor devices relies heavily on proper training and user proficiency. Insufficient training can lead t%li%inaccurate readings, misinterpretation of results, and compromised diabetes management. Improper device usage due t%li%lack of training can lead t%li%inaccurate glucose measurements. Users may not follow proper Monitor procedures, leading t%li%errors in obtaining blood samples or incorrect handling of Monitor strips, which can affect the reliability of results. Users wh%li%lack proper training may not consistently perform glucose tests as recommended. Inconsistent Monitor practices can lead t%li%gaps in monitoring, hindering the effectiveness of diabetes management plans. Interpreting glucose test results correctly is crucial for making informed treatment decisions. Inadequate training can lead t%li%misinterpretation of results, resulting in inappropriate adjustments t%li%medication, insulin dosages, or lifestyle behaviors.
Quality Control and Maintenance
Quality control and maintenance are critical challenges in the Global Point of Care Glucose Monitor (POCT) market. Ensuring the ongoing accuracy and reliability of glucose Monitor devices is essential for effective diabetes management. Without proper quality control and maintenance, devices may produce inaccurate readings, leading t%li%incorrect treatment decisions and compromised patient safety. Over time, Point-of-Care Glucose Testing devices can experience wear and tear that affects their performance. Inadequate maintenance and regular use can lead t%li%device degradation, resulting in inaccurate readings. Point-of-Care Glucose Testing devices require regular calibration t%li%maintain accuracy. Without proper calibration, the readings can drift from the true values, leading t%li%incorrect treatment decisions. Improper cleaning, handling, or storage by users can introduce errors and contaminants int%li%the Monitor process. Regular quality control measures and maintenance practices are necessary t%li%mitigate the impact of user errors. Contaminants from blood samples or external sources can affect the accuracy of glucose measurements. Quality control measures are essential t%li%identify and address contamination issues. Environmental conditions such as temperature and humidity can impact the performance of glucose Monitor devices. Without proper maintenance, these factors can contribute t%li%inaccuracies.
Key Market Trends
Rise of Continuous Glucose Monitoring (CGM)
The rise of Continuous Glucose Monitoring (CGM) is a significant trend in the Global Point of Care Glucose Monitor (POCT) market, offering a new paradigm for diabetes management. CGM systems have gained popularity due t%li%their ability t%li%provide real-time, continuous data on glucose levels, enabling more proactive and personalized diabetes care. CGM systems provide continuous, real-time data on glucose levels, allowing patients and healthcare professionals t%li%monitor trends, fluctuations, and patterns throughout the day and night. CGM systems offer alerts and alarms for hypo- and hyperglycemic events, enabling timely interventions t%li%prevent dangerous glucose fluctuations. CGM systems significantly reduce the need for frequent fingerstick Monitor, offering a less invasive and more convenient way t%li%monitor glucose levels.
CGM data provides insights int%li%how diet, exercise, medication, and other factors affect glucose levels, enabling more personalized treatment adjustments and lifestyle modifications. CGM data can guide healthcare providers in making informed decisions about insulin dosing, medication regimens, and overall diabetes management strategies. The real-time nature of CGM data engages patients in their own care, encouraging them t%li%make timely adjustments and better manage their glucose levels. CGM systems help reduce the frequency and severity of hypoglycemic and hyperglycemic events by providing early warnings and insights int%li%glucose trends. CGM is particularly beneficial for children and older adults wh%li%may have difficulty with frequent fingerstick Monitor. CGM systems offer caregivers and parents continuous insight int%li%glucose levels.
Segmental Insights
Product Type Insights
In 2023, the point-of-care glucose testing market was dominated by the Accu-check Inform II segment and is predicted t%li%continue expanding over the coming years. This product is known for its accuracy and reliability in glucose measurements. Healthcare providers and patients rely on accurate results for making informed treatment decisions. The system's user-friendly design, intuitive interface, and simple Monitor procedure make it accessible t%li%healthcare professionals with varying levels of experience. The Accu-Chek Inform II system provides quick results, allowing healthcare providers t%li%make timely treatment decisions and adjustments.
The system often includes data management features that allow healthcare providers t%li%track and analyse glucose trends over time, contributing t%li%better diabetes management. Accu-Chek Inform II is commonly used in hospital and clinical settings, where immediate glucose monitoring is crucial for patient care. Its integration with hospital information systems enhances workflow efficiency. The Accu-Chek Inform II system have been clinically validated and supported by research, further establishing its credibility and trustworthiness among healthcare professionals.
Regional Insights
The North America region has emerged as the frontrunner in the global point-of-care glucose testing market, solidifying its position through a combination of advanced healthcare infrastructure, extensive research facilities, and a steadfast commitment t%li%patient well-being. Particularly in the United States and Canada, the healthcare landscape is characterized by state-of-the-art medical facilities, renowned research institutions, and a robust emphasis on delivering high-quality care t%li%individuals. This conducive environment has facilitated the widespread adoption and utilization of point-of-care glucose testing devices, which play a crucial role in managing diabetes, a condition with a significant prevalence rate across North America. With diabetes being a prevalent health concern in the region, there is a pressing need for effective glucose monitoring solutions, making point-of-care glucose testing devices indispensable tools in healthcare settings.
North America boasts a high level of awareness regarding the importance of regular glucose monitoring and diabetes management, both among healthcare professionals and patients. This heightened awareness has translated int%li%increased acceptance and utilization of point-of-care glucose testing devices as essential components of diabetes care protocols. The region serves as a hotbed for technological innovation, particularly in the realm of medical device development. Numerous companies in North America are at the forefront of creating cutting-edge point-of-care glucose testing devices that prioritize accuracy, convenience, and user-friendly features. This ongoing innovation drives the evolution of glucose monitoring technology, ensuring that patients have access t%li%the most advanced and effective tools for managing their health.
Key Market Players
In this report, the Global Point-of-Care Glucose Testing Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Point-of-Care Glucose Testing Market.
Available Customizations:
Global Point-of-Care Glucose Testing Market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
Increasing Prevalence of Diabetes Drives The Market Growth
The increasing prevalence of diabetes is a significant driver behind the growth of the global Point of Care Glucose Monitor (POCT) market. Diabetes is a chronic medical condition characterized by elevated blood glucose levels, and its rising prevalence has created a strong demand for effective and convenient glucose monitoring solutions. People with diabetes require regular monitoring of their blood glucose levels t%li%manage the disease effectively. Monitoring helps them make informed decisions about diet, exercise, medication, and insulin dosages. Point-of-Care Glucose Testing provides a quick and convenient way t%li%monitor blood glucose levels without the need for laboratory visits, making it easier for individuals t%li%adhere t%li%their monitoring regimen. Early detection of diabetes and prediabetes is crucial for preventing complications and managing the disease.
As the prevalence of diabetes increases, there is a greater emphasis on early diagnosis and intervention t%li%prevent or delay the onset of complications such as cardiovascular diseases, kidney problems, and nerve damage. Point-of-Care Glucose Testing enables timely detection and intervention, leading t%li%better outcomes for patients. With the increasing prevalence of diabetes, there is a growing focus on patient empowerment and self-management. Point-of-Care Glucose Testing empowers individuals with diabetes t%li%take control of their health by enabling them t%li%monitor their blood glucose levels at home or on the go. This empowerment promotes better engagement in self-care and treatment adherence. The economic burden of diabetes is substantial, with costs associated with medical care, hospitalization, medications, and complications. Healthcare systems are seeking cost-effective solutions t%li%manage diabetes. Point-of-Care Glucose Testing can help reduce costs by minimizing the need for frequent laboratory Monitor and hospital admissions, leading t%li%more efficient resource utilization.
Increasing Demand for Immediate Results
The increasing demand for immediate results is a significant driver behind the growth of the global Point of Care Glucose Monitor (POCT) market. In various healthcare settings, the ability t%li%obtain rapid test results has become a crucial factor for effective patient care and decision-making. For patients with diabetes, prompt adjustments t%li%medication, insulin dosages, and dietary choices are essential for maintaining optimal blood glucose levels. Point-of-Care Glucose Testing provides immediate results, enabling healthcare providers t%li%make real-time decisions about treatment modifications during patient visits. This timely response helps prevent hyperglycemia, hypoglycemia, and associated complications. In emergency departments and critical care units, quick access t%li%diagnostic information is crucial for assessing patients' conditions and determining appropriate interventions. Point-of-Care Glucose Testing allows healthcare professionals t%li%rapidly assess glucose levels in patients wh%li%may be in critical conditions, ensuring timely and appropriate care.
In outpatient settings, primary care clinics, and specialty clinics, healthcare providers often need t%li%make rapid clinical decisions based on test results. Point-of-Care Glucose Testing provides immediate data, allowing clinicians t%li%make informed decisions about treatment plans, medication adjustments, and referrals t%li%specialists. Patients value convenience in healthcare. Immediate test results provided by Point-of-Care Glucose Testing reduce waiting times and the need for follow-up appointments solely for test result discussions. This convenience enhances the patient experience and encourages regular monitoring and engagement in their own care. Point-of-Care Glucose Testing streamlines clinical workflows by eliminating the need t%li%send samples t%li%central laboratories and wait for results. This efficiency benefits both patients and healthcare providers, leading t%li%improved resource utilization and patient throughput. Rapid access t%li%glucose test results helps prevent diabetes-related complications. Healthcare providers can identify glucose fluctuations quickly and intervene t%li%avoid dangerous situations such as hypoglycemic episodes, which can lead t%li%unconsciousness or even death.
Aging Population Drive the Market Growth
The aging population is a significant driver behind the growth of the Point of Care Glucose Monitor (POCT) market. As the global population continues t%li%age, there is a higher prevalence of chronic conditions such as diabetes, which necessitates more frequent and convenient monitoring of blood glucose levels. The aging process is often associated with an increased risk of developing chronic diseases, including type 2 diabetes. Older individuals are more susceptible t%li%insulin resistance and other factors that contribute t%li%elevated blood glucose levels. This results in a higher prevalence of diabetes among the elderly population. Older adults frequently have multiple health conditions that require ongoing management. Diabetes management becomes more complex when combined with other conditions such as hypertension, cardiovascular disease, and kidney problems. Point-of-Care Glucose Testing offers a convenient way t%li%monitor glucose levels, making it easier t%li%integrate diabetes management int%li%the overall care plan.
Healthcare systems are placing greater emphasis on preventive care and early intervention t%li%manage chronic conditions and prevent complications. Point-of-Care Glucose Testing aligns with this approach, allowing healthcare providers t%li%monitor blood glucose levels in older adults and intervene promptly t%li%prevent adverse outcomes. Older adults may experience rapid fluctuations in blood glucose levels due t%li%factors such as medications, changes in diet, and reduced physical activity. Point-of-Care Glucose Testing provides immediate results, enabling healthcare professionals t%li%make timely adjustments t%li%medications and treatment plans t%li%maintain stable glucose levels. Many elderly individuals are on multiple medications. Some medications can impact blood glucose levels, and monitoring glucose levels becomes essential t%li%ensure that medication regimens are well-adjusted and safe for older patients.
Key Market Challenges
Accuracy and Precision
Accuracy and precision are crucial factors in the effectiveness of glucose Monitor, particularly in the Point of Care Glucose Monitor (POCT) market. Inaccurate or imprecise glucose measurements can lead t%li%incorrect treatment decisions, compromised patient safety, and unreliable data for diabetes management. Inaccurate glucose measurements can lead t%li%improper treatment decisions, such as incorrect insulin dosages. This can result in hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), both of which can have serious health consequences, including loss of consciousness or diabetic ketoacidosis. Healthcare providers rely on accurate glucose measurements t%li%make informed treatment decisions. Inaccurate readings can lead t%li%inappropriate adjustments in medication, insulin therapy, or diet, potentially affecting patients' overall health and diabetes management. Inaccurate glucose measurements can lead t%li%suboptimal glycemic control, which is associated with increased risks of diabetes-related complications such as cardiovascular diseases, kidney problems, and neuropathy.
User Training and Proficiency
User training and proficiency are critical challenges in the Global Point of Care Glucose Monitor (POCT) market. The accurate and effective use of glucose Monitor devices relies heavily on proper training and user proficiency. Insufficient training can lead t%li%inaccurate readings, misinterpretation of results, and compromised diabetes management. Improper device usage due t%li%lack of training can lead t%li%inaccurate glucose measurements. Users may not follow proper Monitor procedures, leading t%li%errors in obtaining blood samples or incorrect handling of Monitor strips, which can affect the reliability of results. Users wh%li%lack proper training may not consistently perform glucose tests as recommended. Inconsistent Monitor practices can lead t%li%gaps in monitoring, hindering the effectiveness of diabetes management plans. Interpreting glucose test results correctly is crucial for making informed treatment decisions. Inadequate training can lead t%li%misinterpretation of results, resulting in inappropriate adjustments t%li%medication, insulin dosages, or lifestyle behaviors.
Quality Control and Maintenance
Quality control and maintenance are critical challenges in the Global Point of Care Glucose Monitor (POCT) market. Ensuring the ongoing accuracy and reliability of glucose Monitor devices is essential for effective diabetes management. Without proper quality control and maintenance, devices may produce inaccurate readings, leading t%li%incorrect treatment decisions and compromised patient safety. Over time, Point-of-Care Glucose Testing devices can experience wear and tear that affects their performance. Inadequate maintenance and regular use can lead t%li%device degradation, resulting in inaccurate readings. Point-of-Care Glucose Testing devices require regular calibration t%li%maintain accuracy. Without proper calibration, the readings can drift from the true values, leading t%li%incorrect treatment decisions. Improper cleaning, handling, or storage by users can introduce errors and contaminants int%li%the Monitor process. Regular quality control measures and maintenance practices are necessary t%li%mitigate the impact of user errors. Contaminants from blood samples or external sources can affect the accuracy of glucose measurements. Quality control measures are essential t%li%identify and address contamination issues. Environmental conditions such as temperature and humidity can impact the performance of glucose Monitor devices. Without proper maintenance, these factors can contribute t%li%inaccuracies.
Key Market Trends
Rise of Continuous Glucose Monitoring (CGM)
The rise of Continuous Glucose Monitoring (CGM) is a significant trend in the Global Point of Care Glucose Monitor (POCT) market, offering a new paradigm for diabetes management. CGM systems have gained popularity due t%li%their ability t%li%provide real-time, continuous data on glucose levels, enabling more proactive and personalized diabetes care. CGM systems provide continuous, real-time data on glucose levels, allowing patients and healthcare professionals t%li%monitor trends, fluctuations, and patterns throughout the day and night. CGM systems offer alerts and alarms for hypo- and hyperglycemic events, enabling timely interventions t%li%prevent dangerous glucose fluctuations. CGM systems significantly reduce the need for frequent fingerstick Monitor, offering a less invasive and more convenient way t%li%monitor glucose levels.
CGM data provides insights int%li%how diet, exercise, medication, and other factors affect glucose levels, enabling more personalized treatment adjustments and lifestyle modifications. CGM data can guide healthcare providers in making informed decisions about insulin dosing, medication regimens, and overall diabetes management strategies. The real-time nature of CGM data engages patients in their own care, encouraging them t%li%make timely adjustments and better manage their glucose levels. CGM systems help reduce the frequency and severity of hypoglycemic and hyperglycemic events by providing early warnings and insights int%li%glucose trends. CGM is particularly beneficial for children and older adults wh%li%may have difficulty with frequent fingerstick Monitor. CGM systems offer caregivers and parents continuous insight int%li%glucose levels.
Segmental Insights
Product Type Insights
In 2023, the point-of-care glucose testing market was dominated by the Accu-check Inform II segment and is predicted t%li%continue expanding over the coming years. This product is known for its accuracy and reliability in glucose measurements. Healthcare providers and patients rely on accurate results for making informed treatment decisions. The system's user-friendly design, intuitive interface, and simple Monitor procedure make it accessible t%li%healthcare professionals with varying levels of experience. The Accu-Chek Inform II system provides quick results, allowing healthcare providers t%li%make timely treatment decisions and adjustments.
The system often includes data management features that allow healthcare providers t%li%track and analyse glucose trends over time, contributing t%li%better diabetes management. Accu-Chek Inform II is commonly used in hospital and clinical settings, where immediate glucose monitoring is crucial for patient care. Its integration with hospital information systems enhances workflow efficiency. The Accu-Chek Inform II system have been clinically validated and supported by research, further establishing its credibility and trustworthiness among healthcare professionals.
Regional Insights
The North America region has emerged as the frontrunner in the global point-of-care glucose testing market, solidifying its position through a combination of advanced healthcare infrastructure, extensive research facilities, and a steadfast commitment t%li%patient well-being. Particularly in the United States and Canada, the healthcare landscape is characterized by state-of-the-art medical facilities, renowned research institutions, and a robust emphasis on delivering high-quality care t%li%individuals. This conducive environment has facilitated the widespread adoption and utilization of point-of-care glucose testing devices, which play a crucial role in managing diabetes, a condition with a significant prevalence rate across North America. With diabetes being a prevalent health concern in the region, there is a pressing need for effective glucose monitoring solutions, making point-of-care glucose testing devices indispensable tools in healthcare settings.
North America boasts a high level of awareness regarding the importance of regular glucose monitoring and diabetes management, both among healthcare professionals and patients. This heightened awareness has translated int%li%increased acceptance and utilization of point-of-care glucose testing devices as essential components of diabetes care protocols. The region serves as a hotbed for technological innovation, particularly in the realm of medical device development. Numerous companies in North America are at the forefront of creating cutting-edge point-of-care glucose testing devices that prioritize accuracy, convenience, and user-friendly features. This ongoing innovation drives the evolution of glucose monitoring technology, ensuring that patients have access t%li%the most advanced and effective tools for managing their health.
Key Market Players
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories Inc.
- Nipr%li%Corporation
- Lifescan, Inc.
- Nova Biomedical Corporation
- ACON Laboratories Inc.
- Trividia Health, Inc.
- Prodigy Diabetes Care, LLC
- Ascensia Diabetes Care Holdings AG
- EKF Diagnostics Holdings PLC
In this report, the Global Point-of-Care Glucose Testing Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Point-of-Care Glucose Testing Market, By Product Type:
- Accu Check Aviva Meter
- Onetouch Veri%li%Flex
- i-STAT
- Bayer CONTOUR Blood Glucose Monitoring System
- Freestyle Lite
- True Metrix
- Accu-Chek Inform II
- StatStrip
- Others
- Point-of-Care Glucose Testing Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
- Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Point-of-Care Glucose Testing Market.
Available Customizations:
Global Point-of-Care Glucose Testing Market report with the given market data, Tech Sci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others)
5.2.2. By Company (2023)
5.2.3. By Region
5.3. Market Map
6. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Point-of-Care Glucose Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.2. Mexico Point-of-Care Glucose Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.3. Canada Point-of-Care Glucose Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
7. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. France Point-of-Care Glucose Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.2. Germany Point-of-Care Glucose Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.3. United Kingdom Point-of-Care Glucose Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.4. Italy Point-of-Care Glucose Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.5. Spain Point-of-Care Glucose Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
8. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Point-of-Care Glucose Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.2. India Point-of-Care Glucose Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.3. South Korea Point-of-Care Glucose Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.4. Japan Point-of-Care Glucose Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.5. Australia Point-of-Care Glucose Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
9. SOUTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Point-of-Care Glucose Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.2. Argentina Point-of-Care Glucose Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.3. Colombia Point-of-Care Glucose Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
10. MIDDLE EAST AND AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Point-of-Care Glucose Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.2. Saudi Arabia Point-of-Care Glucose Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.3. UAE Point-of-Care Glucose Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. F. Hoffmann-La Roche Ltd
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Abbott Laboratories Inc.
15.3. Nipro Corporation
15.4. Lifescan, Inc.
15.5. Nova Biomedical Corporation
15.6. ACON Laboratories Inc.
15.7. Trividia Health, Inc.
15.8. Prodigy Diabetes Care, LLC
15.9. Ascensia Diabetes Care Holdings AG
15.10. EKF Diagnostics Holdings PLC
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others)
5.2.2. By Company (2023)
5.2.3. By Region
5.3. Market Map
6. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Point-of-Care Glucose Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.2. Mexico Point-of-Care Glucose Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.3. Canada Point-of-Care Glucose Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
7. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. France Point-of-Care Glucose Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.2. Germany Point-of-Care Glucose Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.3. United Kingdom Point-of-Care Glucose Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.4. Italy Point-of-Care Glucose Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.5. Spain Point-of-Care Glucose Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
8. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Point-of-Care Glucose Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.2. India Point-of-Care Glucose Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.3. South Korea Point-of-Care Glucose Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.4. Japan Point-of-Care Glucose Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.5. Australia Point-of-Care Glucose Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
9. SOUTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Point-of-Care Glucose Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.2. Argentina Point-of-Care Glucose Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.3. Colombia Point-of-Care Glucose Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
10. MIDDLE EAST AND AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Point-of-Care Glucose Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.2. Saudi Arabia Point-of-Care Glucose Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.3. UAE Point-of-Care Glucose Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. F. Hoffmann-La Roche Ltd
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Abbott Laboratories Inc.
15.3. Nipro Corporation
15.4. Lifescan, Inc.
15.5. Nova Biomedical Corporation
15.6. ACON Laboratories Inc.
15.7. Trividia Health, Inc.
15.8. Prodigy Diabetes Care, LLC
15.9. Ascensia Diabetes Care Holdings AG
15.10. EKF Diagnostics Holdings PLC
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
